- Home
- IBG vs NUWE Comparison
IBG vs NUWE Comparison
Compare IBG & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IBG | NUWE |
|---|---|---|
| Founded | 2018 | 1999 |
| Country | Australia | United States |
| Employees | 9 | 38 |
| Industry | Beverages (Production/Distribution) | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5M | 1.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | IBG | NUWE |
|---|---|---|
| Price | $0.74 | $0.76 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 92.0K | 45.2K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $11.14 |
| Revenue Next Year | N/A | $18.51 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.30 | $0.19 |
| 52 Week High | $6.50 | $25.95 |
Technical Indicators
Market Signals| Indicator | IBG | NUWE |
|---|---|---|
| Relative Strength Index (RSI) | 31.09 | 22.02 |
| Support Level | $0.69 | N/A |
| Resistance Level | $1.31 | $1.18 |
| Average True Range (ATR) | 0.08 | 0.08 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 16.11 | 6.45 |
Price Performance
Historical ComparisonAbout IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.